TapImmune Inc. Share Price OTC Bulletin Board
Equities
TPIV
US8760334081
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 34.5M 2.71B |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.33B | Net income 2025 * | -31M -2.43B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.02
x | P/E ratio 2025 * |
-3.02
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.8% |
Latest transcript on TapImmune Inc.
Managers | Title | Age | Since |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 16/10/18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/10/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 16/10/18 |
Steven Elms
BRD | Director/Board Member | 60 | 05/08/19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 07/12/21 |
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |